Detail akcie SurModics online

Business Summary: Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Financial Summary: BRIEF: For the six months ended 31 March 2024, Surmodics Inc revenues increased 20% to $62.5M. Net loss decreased 97% to $539K. Revenues reflect Medical Device segment increase of 25% to $48.4M, In Vitro Diagnostics segment increase of 5% to $14.1M. Lower net loss reflects Medical Device segment income totaling $78K vs. loss of $14.3M. Basic Earnings per Share excluding Extraordinary Items increased from -$1.11 to -$0.04.